It contains the active ingredient semaglutide and functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of drugs that mimic the action of the GLP-1 hormone, which plays a crucial role in regulating blood sugar levels
Seamless communication with your care team ensures any concerns or treatment adjustments are promptly addressed
GLP-1 can stimulate pancreatic -cells to release insulin.236,237 Insulin not only directly lowers blood glucose levels but also further inhibits glucagon secretion from -cells through a feedback mechanism.238 The high concentration of insulin in the local pancreatic environment creates a negative feedback effect, reducing the amount of glucagon secreted by -cells.234 Additionally, GLP-1 can reduce blood glucose production by delaying gastric emptying and decreasing appetite, which also contributes to overall blood glucose control.239,240 In summary, GLP-1 lowers blood glucose levels and inhibits glucagon secretion through direct action on -cells, promotion of insulin secretion, and regulation of gastrointestinal activity.241 GLP-1R is expressed not only on -cells and -cells but also on -cells in the pancreatic islets.242 -cells primarily secrete somatostatin, which is an important regulatory hormone.242 The expression of GLP-1R on -cells helps to inhibit the secretion of glucagon.242 When GLP-1 binds to GLP-1R on -cells, it activates these cells and promotes the secretion of somatostatin.243 Somatostatin is a potent inhibitory hormone that affects the surrounding -cells and -cells
While semaglutide controls appetite and improves blood sugar regulation, lipotropic injections enhance the bodys ability to metabolize fat and boost energy levels
Partial sequence of body protection compound from human gastric juice
You might recognize it by its brand names, Wegovy and Ozempic, with Wegovy specifically approved for weight management and Ozempic for type 2 diabetes management
.png)
